APO Research
Talk to an analyst

APO RESEARCH · REPORT

PVA Foam Embolization Particles

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global PVA Foam Embolization Particles Industry Growth and Trends Forecast to 2032

20 December 202591 pages

Choose your research edition.

Industry ResearchPVA Foam Embolization Particles Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal PVA Foam Embolization Particles Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal PVA Foam Embolization Particles Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PVA Foam Embolization Particles Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal PVA Foam Embolization Particles Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global PVA Foam Embolization Particles market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for PVA Foam Embolization Particles is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for PVA Foam Embolization Particles is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for PVA Foam Embolization Particles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of PVA Foam Embolization Particles include Terumo, Sirtex Medical, Merit Medical, INterface BIOmaterials, HENGRUI Medical, Cook Medical, BTG Medical, Boston Scientific and Alicon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global PVA Foam Embolization Particles market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The PVA Foam Embolization Particles market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global PVA Foam Embolization Particles market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to PVA Foam Embolization Particles.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global PVA Foam Embolization Particles market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

PVA Foam Embolization Particles Market by Company

Terumo

Sirtex Medical

Merit Medical

INterface BIOmaterials

HENGRUI Medical

Cook Medical

BTG Medical

Boston Scientific

Alicon

PVA Foam Embolization Particles Segment by Type

50μm～350μm

350μm～560μm

560μm～710μm

710μm～1000μm

1000μm～1400μm

1400μm～2000μm

PVA Foam Embolization Particles Segment by Application

Trauma Embolization

Liver Tumor Embolization

Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)

Uterine Fibroid Embolization

Others

PVA Foam Embolization Particles Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PVA Foam Embolization Particles market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PVA Foam Embolization Particles and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PVA Foam Embolization Particles.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of PVA Foam Embolization Particles manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of PVA Foam Embolization Particles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 50μm～350μm Table 2. Major Company of 350μm～560μm Table 3. Major Company of 560μm～710μm Table 4. Major Company of 710μm～1000μm Table 5. Major Company of 1000μm～1400μm Table 6. Major Company of 1400μm～2000μm Table 7. Global PVA Foam Embolization Particles Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global PVA Foam Embolization Particles Sales by Type (2021-2026) & (k units) Table 9. Global PVA Foam Embolization Particles Sales Market Share in Volume by Type (2021-2026) Table 10. Global PVA Foam Embolization Particles Sales by Type (2021-2026) & (US$ Million) Table 11. Global PVA Foam Embolization Particles Sales Market Share in Value by Type (2021-2026) Table 12. Global PVA Foam Embolization Particles Price by Type (2021-2026) & (US$/unit) Table 13. Global PVA Foam Embolization Particles Sales by Type (2027-2032) & (k units) Table 14. Global PVA Foam Embolization Particles Sales Market Share in Volume by Type (2027-2032) Table 15. Global PVA Foam Embolization Particles Sales by Type (2027-2032) & (US$ Million) Table 16. Global PVA Foam Embolization Particles Sales Market Share in Value by Type (2027-2032) Table 17. Global PVA Foam Embolization Particles Price by Type (2027-2032) & (US$/unit) Table 18. North America PVA Foam Embolization Particles Sales by Type (2021-2026) & (k units) Table 19. North America PVA Foam Embolization Particles Sales by Type (2021-2026) & (US$ Million) Table 20. Europe PVA Foam Embolization Particles Sales by Type (2021-2026) & (k units) Table 21. Europe PVA Foam Embolization Particles Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific PVA Foam Embolization Particles Sales by Type (2021-2026) & (k units) Table 23. Asia-Pacific PVA Foam Embolization Particles Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America PVA Foam Embolization Particles Sales by Type (2021-2026) & (k units) Table 25. Latin America PVA Foam Embolization Particles Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa PVA Foam Embolization Particles Sales by Type (2021-2026) & (k units) Table 27. Middle East and Africa PVA Foam Embolization Particles Sales by Type (2021-2026) & (US$ Million) Table 28. PVA Foam Embolization Particles Industry Trends Table 29. PVA Foam Embolization Particles Industry Drivers Table 30. PVA Foam Embolization Particles Industry Opportunities and Challenges Table 31. PVA Foam Embolization Particles Industry Restraints Table 32. Global PVA Foam Embolization Particles Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global PVA Foam Embolization Particles Revenue Market Share by Company (2021-2026) Table 34. Global PVA Foam Embolization Particles Sales by Company (2021-2026) & (k units) Table 35. Global PVA Foam Embolization Particles Sales Share by Company (2021-2026) Table 36. Global PVA Foam Embolization Particles Market Price by Company (2021-2026) & (US$/unit) Table 37. Global PVA Foam Embolization Particles Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global PVA Foam Embolization Particles Major Company Production Sites and Headquarters Table 39. Global PVA Foam Embolization Particles Company, Product Type & Application Table 40. Global PVA Foam Embolization Particles Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global PVA Foam Embolization Particles by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global PVA Foam Embolization Particles Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global PVA Foam Embolization Particles Sales by Region (2021-2026) & (k units) Table 45. Global PVA Foam Embolization Particles Sales Market Share in Volume by Region (2021-2026) Table 46. Global PVA Foam Embolization Particles Sales by Region (2021-2026) & (US$ Million) Table 47. Global PVA Foam Embolization Particles Sales Market Share in Value by Region (2021-2026) Table 48. Global PVA Foam Embolization Particles Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 49. Global PVA Foam Embolization Particles Sales by Region (2027-2032) & (k units) Table 50. Global PVA Foam Embolization Particles Sales Market Share in Volume by Region (2027-2032) Table 51. Global PVA Foam Embolization Particles Sales by Region (2027-2032) & (US$ Million) Table 52. Global PVA Foam Embolization Particles Sales Market Share in Value by Region (2027-2032) Table 53. Global PVA Foam Embolization Particles Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 54. Global PVA Foam Embolization Particles Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global PVA Foam Embolization Particles Sales by Application (2021-2026) & (k units) Table 56. Global PVA Foam Embolization Particles Sales Market Share in Volume by Application (2021-2026) Table 57. Global PVA Foam Embolization Particles Sales by Application (2021-2026) & (US$ Million) Table 58. Global PVA Foam Embolization Particles Sales Market Share in Value by Application (2021-2026) Table 59. Global PVA Foam Embolization Particles Price by Application (2021-2026) & (US$/unit) Table 60. Global PVA Foam Embolization Particles Sales by Application (2027-2032) & (k units) Table 61. Global PVA Foam Embolization Particles Sales Market Share in Volume by Application (2027-2032) Table 62. Global PVA Foam Embolization Particles Sales by Application (2027-2032) & (US$ Million) Table 63. Global PVA Foam Embolization Particles Sales Market Share in Value by Application (2027-2032) Table 64. Global PVA Foam Embolization Particles Price by Application (2027-2032) & (US$/unit) Table 65. North America PVA Foam Embolization Particles Sales by Application (2021-2026) & (k units) Table 66. North America PVA Foam Embolization Particles Sales by Application (2021-2026) & (US$ Million) Table 67. Europe PVA Foam Embolization Particles Sales by Application (2021-2026) & (k units) Table 68. Europe PVA Foam Embolization Particles Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific PVA Foam Embolization Particles Sales by Application (2021-2026) & (k units) Table 70. Asia-Pacific PVA Foam Embolization Particles Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America PVA Foam Embolization Particles Sales by Application (2021-2026) & (k units) Table 72. Latin America PVA Foam Embolization Particles Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa PVA Foam Embolization Particles Sales by Application (2021-2026) & (k units) Table 74. Middle East and Africa PVA Foam Embolization Particles Sales by Application (2021-2026) & (US$ Million) Table 75. Terumo Company Information Table 76. Terumo Business Overview Table 77. Terumo PVA Foam Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Terumo PVA Foam Embolization Particles Product Portfolio Table 79. Terumo Recent Development Table 80. Sirtex Medical Company Information Table 81. Sirtex Medical Business Overview Table 82. Sirtex Medical PVA Foam Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Sirtex Medical PVA Foam Embolization Particles Product Portfolio Table 84. Sirtex Medical Recent Development Table 85. Merit Medical Company Information Table 86. Merit Medical Business Overview Table 87. Merit Medical PVA Foam Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Merit Medical PVA Foam Embolization Particles Product Portfolio Table 89. Merit Medical Recent Development Table 90. INterface BIOmaterials Company Information Table 91. INterface BIOmaterials Business Overview Table 92. INterface BIOmaterials PVA Foam Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. INterface BIOmaterials PVA Foam Embolization Particles Product Portfolio Table 94. INterface BIOmaterials Recent Development Table 95. HENGRUI Medical Company Information Table 96. HENGRUI Medical Business Overview Table 97. HENGRUI Medical PVA Foam Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. HENGRUI Medical PVA Foam Embolization Particles Product Portfolio Table 99. HENGRUI Medical Recent Development Table 100. Cook Medical Company Information Table 101. Cook Medical Business Overview Table 102. Cook Medical PVA Foam Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Cook Medical PVA Foam Embolization Particles Product Portfolio Table 104. Cook Medical Recent Development Table 105. BTG Medical Company Information Table 106. BTG Medical Business Overview Table 107. BTG Medical PVA Foam Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. BTG Medical PVA Foam Embolization Particles Product Portfolio Table 109. BTG Medical Recent Development Table 110. Boston Scientific Company Information Table 111. Boston Scientific Business Overview Table 112. Boston Scientific PVA Foam Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Boston Scientific PVA Foam Embolization Particles Product Portfolio Table 114. Boston Scientific Recent Development Table 115. Alicon Company Information Table 116. Alicon Business Overview Table 117. Alicon PVA Foam Embolization Particles Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Alicon PVA Foam Embolization Particles Product Portfolio Table 119. Alicon Recent Development Table 120. North America PVA Foam Embolization Particles Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 121. North America PVA Foam Embolization Particles Sales by Country (2021-2026) & (k units) Table 122. North America PVA Foam Embolization Particles Sales Market Share by Country (2021-2026) Table 123. North America PVA Foam Embolization Particles Sales Forecast by Country (2027-2032) & (k units) Table 124. North America PVA Foam Embolization Particles Sales Market Share Forecast by Country (2027-2032) Table 125. North America PVA Foam Embolization Particles Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. North America PVA Foam Embolization Particles Market Size by Country (2021-2026) & (US$ Million) Table 127. North America PVA Foam Embolization Particles Market Share by Country (2021-2026) Table 128. North America PVA Foam Embolization Particles Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. North America PVA Foam Embolization Particles Market Share Forecast by Country (2027-2032) Table 130. Europe PVA Foam Embolization Particles Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 131. Europe PVA Foam Embolization Particles Sales by Country (2021-2026) & (k units) Table 132. Europe PVA Foam Embolization Particles Sales Market Share by Country (2021-2026) Table 133. Europe PVA Foam Embolization Particles Sales Forecast by Country (2027-2032) & (k units) Table 134. Europe PVA Foam Embolization Particles Sales Market Share Forecast by Country (2027-2032) Table 135. Europe PVA Foam Embolization Particles Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Europe PVA Foam Embolization Particles Market Size by Country (2021-2026) & (US$ Million) Table 137. Europe PVA Foam Embolization Particles Market Share by Country (2021-2026) Table 138. Europe PVA Foam Embolization Particles Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Europe PVA Foam Embolization Particles Market Share Forecast by Country (2027-2032) Table 140. Asia-Pacific PVA Foam Embolization Particles Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 141. Asia-Pacific PVA Foam Embolization Particles Sales by Country (2021-2026) & (k units) Table 142. Asia-Pacific PVA Foam Embolization Particles Sales Market Share by Country (2021-2026) Table 143. Asia-Pacific PVA Foam Embolization Particles Sales Forecast by Country (2027-2032) & (k units) Table 144. Asia-Pacific PVA Foam Embolization Particles Sales Market Share Forecast by Country (2027-2032) Table 145. Asia-Pacific PVA Foam Embolization Particles Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Asia-Pacific PVA Foam Embolization Particles Market Size by Country (2021-2026) & (US$ Million) Table 147. Asia-Pacific PVA Foam Embolization Particles Market Share by Country (2021-2026) Table 148. Asia-Pacific PVA Foam Embolization Particles Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Asia-Pacific PVA Foam Embolization Particles Market Share Forecast by Country (2027-2032) Table 150. Latin America PVA Foam Embolization Particles Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 151. Latin America PVA Foam Embolization Particles Sales by Country (2021-2026) & (k units) Table 152. Latin America PVA Foam Embolization Particles Sales Market Share by Country (2021-2026) Table 153. Latin America PVA Foam Embolization Particles Sales Forecast by Country (2027-2032) & (k units) Table 154. Latin America PVA Foam Embolization Particles Sales Market Share Forecast by Country (2027-2032) Table 155. Latin America PVA Foam Embolization Particles Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Latin America PVA Foam Embolization Particles Market Size by Country (2021-2026) & (US$ Million) Table 157. Latin America PVA Foam Embolization Particles Market Share by Country (2021-2026) Table 158. Latin America PVA Foam Embolization Particles Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Latin America PVA Foam Embolization Particles Market Share Forecast by Country (2027-2032) Table 160. Middle East and Africa PVA Foam Embolization Particles Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 161. Middle East and Africa PVA Foam Embolization Particles Sales by Country (2021-2026) & (k units) Table 162. Middle East and Africa PVA Foam Embolization Particles Sales Market Share by Country (2021-2026) Table 163. Middle East and Africa PVA Foam Embolization Particles Sales Forecast by Country (2027-2032) & (k units) Table 164. Middle East and Africa PVA Foam Embolization Particles Sales Market Share Forecast by Country (2027-2032) Table 165. Middle East and Africa PVA Foam Embolization Particles Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. Middle East and Africa PVA Foam Embolization Particles Market Size by Country (2021-2026) & (US$ Million) Table 167. Middle East and Africa PVA Foam Embolization Particles Market Share by Country (2021-2026) Table 168. Middle East and Africa PVA Foam Embolization Particles Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. Middle East and Africa PVA Foam Embolization Particles Market Share Forecast by Country (2027-2032) Table 170. Key Raw Materials Table 171. Raw Materials Key Suppliers Table 172. PVA Foam Embolization Particles Distributors List Table 173. PVA Foam Embolization Particles Customers List Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. PVA Foam Embolization Particles Image Figure 2. Global PVA Foam Embolization Particles Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PVA Foam Embolization Particles Market Size (2021-2032) & (US$ Million) Figure 4. Global PVA Foam Embolization Particles Sales (2021-2032) & (k units) Figure 5. 50μm～350μm Image Figure 6. Global 50μm～350μm Sales YoY Growth (2021-2032) & (k units) Figure 7. 350μm～560μm Image Figure 8. Global 350μm～560μm Sales YoY Growth (2021-2032) & (k units) Figure 9. 560μm～710μm Image Figure 10. Global 560μm～710μm Sales YoY Growth (2021-2032) & (k units) Figure 11. 710μm～1000μm Image Figure 12. Global 710μm～1000μm Sales YoY Growth (2021-2032) & (k units) Figure 13. 1000μm～1400μm Image Figure 14. Global 1000μm～1400μm Sales YoY Growth (2021-2032) & (k units) Figure 15. 1400μm～2000μm Image Figure 16. Global 1400μm～2000μm Sales YoY Growth (2021-2032) & (k units) Figure 17. Global PVA Foam Embolization Particles Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global PVA Foam Embolization Particles Market Share by Type 2025 VS 2032 Figure 19. North America PVA Foam Embolization Particles Sales Market Share in Volume by Type in 2025 Figure 20. North America PVA Foam Embolization Particles Sales Market Share in Value by Type in 2025 Figure 21. Europe PVA Foam Embolization Particles Sales Market Share in Volume by Type in 2025 Figure 22. Europe PVA Foam Embolization Particles Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific PVA Foam Embolization Particles Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific PVA Foam Embolization Particles Sales Market Share in Value by Type in 2025 Figure 25. Latin America PVA Foam Embolization Particles Sales Market Share in Volume by Type in 2025 Figure 26. Latin America PVA Foam Embolization Particles Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa PVA Foam Embolization Particles Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa PVA Foam Embolization Particles Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 PVA Foam Embolization Particles Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Trauma Embolization Image Figure 32. Global Trauma Embolization Sales YoY Growth (2021-2032) & (k units) Figure 33. Liver Tumor Embolization Image Figure 34. Global Liver Tumor Embolization Sales YoY Growth (2021-2032) & (k units) Figure 35. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Image Figure 36. Global Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Sales YoY Growth (2021-2032) & (k units) Figure 37. Uterine Fibroid Embolization Image Figure 38. Global Uterine Fibroid Embolization Sales YoY Growth (2021-2032) & (k units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 41. Global PVA Foam Embolization Particles Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global PVA Foam Embolization Particles Market Share by Application 2025 VS 2032 Figure 43. North America PVA Foam Embolization Particles Sales Market Share in Volume by Application in 2025 Figure 44. North America PVA Foam Embolization Particles Sales Market Share in Value by Application in 2025 Figure 45. Europe PVA Foam Embolization Particles Sales Market Share in Volume by Application in 2025 Figure 46. Europe PVA Foam Embolization Particles Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific PVA Foam Embolization Particles Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific PVA Foam Embolization Particles Sales Market Share in Value by Application in 2025 Figure 49. Latin America PVA Foam Embolization Particles Sales Market Share in Volume by Application in 2025 Figure 50. Latin America PVA Foam Embolization Particles Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa PVA Foam Embolization Particles Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa PVA Foam Embolization Particles Sales Market Share in Value by Application in 2025 Figure 53. North America PVA Foam Embolization Particles Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. North America PVA Foam Embolization Particles Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America PVA Foam Embolization Particles Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America PVA Foam Embolization Particles Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe PVA Foam Embolization Particles Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Europe PVA Foam Embolization Particles Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe PVA Foam Embolization Particles Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe PVA Foam Embolization Particles Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific PVA Foam Embolization Particles Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Asia-Pacific PVA Foam Embolization Particles Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific PVA Foam Embolization Particles Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific PVA Foam Embolization Particles Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America PVA Foam Embolization Particles Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Latin America PVA Foam Embolization Particles Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America PVA Foam Embolization Particles Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America PVA Foam Embolization Particles Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa PVA Foam Embolization Particles Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 70. Middle East and Africa PVA Foam Embolization Particles Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa PVA Foam Embolization Particles Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa PVA Foam Embolization Particles Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. PVA Foam Embolization Particles Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. PVA Foam Embolization Particles Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • 50μm～350μm
  • 350μm～560μm
  • 560μm～710μm
  • 710μm～1000μm
  • 1000μm～1400μm
  • 1400μm～2000μm
Applications
  • Trauma Embolization
  • Liver Tumor Embolization
  • Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
  • Uterine Fibroid Embolization
  • Others
Companies covered
  • Terumo
  • Sirtex Medical
  • Merit Medical
  • INterface BIOmaterials
  • HENGRUI Medical
  • Cook Medical
  • BTG Medical
  • Boston Scientific
  • Alicon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global PVA Foam Embolization Particles Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global PVA Foam Embolization Particles Sales Estimates and Forecasts (2021-2032)
  5. 1.3 PVA Foam Embolization Particles Market by Type
  6. 1.3.1 50μm～350μm
  7. 1.3.2 350μm～560μm
  8. 1.3.3 560μm～710μm
  9. 1.3.4 710μm～1000μm
  10. 1.3.5 1000μm～1400μm
  11. 1.3.6 1400μm～2000μm
  12. 1.4 Global PVA Foam Embolization Particles Market Size by Type
  13. 1.4.1 Global PVA Foam Embolization Particles Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global PVA Foam Embolization Particles Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global PVA Foam Embolization Particles Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America PVA Foam Embolization Particles Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe PVA Foam Embolization Particles Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific PVA Foam Embolization Particles Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America PVA Foam Embolization Particles Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa PVA Foam Embolization Particles Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 PVA Foam Embolization Particles Industry Trends
  2. 2.2 PVA Foam Embolization Particles Industry Drivers
  3. 2.3 PVA Foam Embolization Particles Industry Opportunities and Challenges
  4. 2.4 PVA Foam Embolization Particles Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by PVA Foam Embolization Particles Revenue (2021-2026)
  2. 3.2 Global Top Players by PVA Foam Embolization Particles Sales (2021-2026)
  3. 3.3 Global Top Players by PVA Foam Embolization Particles Price (2021-2026)
  4. 3.4 Global PVA Foam Embolization Particles Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global PVA Foam Embolization Particles Major Company Production Sites & Headquarters
  6. 3.6 Global PVA Foam Embolization Particles Company, Product Type & Application
  7. 3.7 Global PVA Foam Embolization Particles Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global PVA Foam Embolization Particles Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 PVA Foam Embolization Particles Players Market Share by Revenue in 2025
  11. 3.8.3 2025 PVA Foam Embolization Particles Tier 1, Tier 2, and Tier 3
4 PVA Foam Embolization Particles Regional Status and Outlook
  1. 4.1 Global PVA Foam Embolization Particles Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global PVA Foam Embolization Particles Historic Market Size by Region
  3. 4.2.1 Global PVA Foam Embolization Particles Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global PVA Foam Embolization Particles Sales in Value by Region (2021-2026)
  5. 4.2.3 Global PVA Foam Embolization Particles Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global PVA Foam Embolization Particles Forecasted Market Size by Region
  7. 4.3.1 Global PVA Foam Embolization Particles Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global PVA Foam Embolization Particles Sales in Value by Region (2027-2032)
  9. 4.3.3 Global PVA Foam Embolization Particles Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 PVA Foam Embolization Particles by Application
  1. 5.1 PVA Foam Embolization Particles Market by Application
  2. 5.1.1 Trauma Embolization
  3. 5.1.2 Liver Tumor Embolization
  4. 5.1.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
  5. 5.1.4 Uterine Fibroid Embolization
  6. 5.1.5 Others
  7. 5.2 Global PVA Foam Embolization Particles Market Size by Application
  8. 5.2.1 Global PVA Foam Embolization Particles Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global PVA Foam Embolization Particles Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global PVA Foam Embolization Particles Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America PVA Foam Embolization Particles Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe PVA Foam Embolization Particles Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific PVA Foam Embolization Particles Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America PVA Foam Embolization Particles Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa PVA Foam Embolization Particles Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Terumo
  2. 6.1.1 Terumo Company Information
  3. 6.1.2 Terumo Business Overview
  4. 6.1.3 Terumo PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Terumo PVA Foam Embolization Particles Product Portfolio
  6. 6.1.5 Terumo Recent Developments
  7. 6.2 Sirtex Medical
  8. 6.2.1 Sirtex Medical Company Information
  9. 6.2.2 Sirtex Medical Business Overview
  10. 6.2.3 Sirtex Medical PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sirtex Medical PVA Foam Embolization Particles Product Portfolio
  12. 6.2.5 Sirtex Medical Recent Developments
  13. 6.3 Merit Medical
  14. 6.3.1 Merit Medical Company Information
  15. 6.3.2 Merit Medical Business Overview
  16. 6.3.3 Merit Medical PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merit Medical PVA Foam Embolization Particles Product Portfolio
  18. 6.3.5 Merit Medical Recent Developments
  19. 6.4 INterface BIOmaterials
  20. 6.4.1 INterface BIOmaterials Company Information
  21. 6.4.2 INterface BIOmaterials Business Overview
  22. 6.4.3 INterface BIOmaterials PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 INterface BIOmaterials PVA Foam Embolization Particles Product Portfolio
  24. 6.4.5 INterface BIOmaterials Recent Developments
  25. 6.5 HENGRUI Medical
  26. 6.5.1 HENGRUI Medical Company Information
  27. 6.5.2 HENGRUI Medical Business Overview
  28. 6.5.3 HENGRUI Medical PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 HENGRUI Medical PVA Foam Embolization Particles Product Portfolio
  30. 6.5.5 HENGRUI Medical Recent Developments
  31. 6.6 Cook Medical
  32. 6.6.1 Cook Medical Company Information
  33. 6.6.2 Cook Medical Business Overview
  34. 6.6.3 Cook Medical PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cook Medical PVA Foam Embolization Particles Product Portfolio
  36. 6.6.5 Cook Medical Recent Developments
  37. 6.7 BTG Medical
  38. 6.7.1 BTG Medical Company Information
  39. 6.7.2 BTG Medical Business Overview
  40. 6.7.3 BTG Medical PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 BTG Medical PVA Foam Embolization Particles Product Portfolio
  42. 6.7.5 BTG Medical Recent Developments
  43. 6.8 Boston Scientific
  44. 6.8.1 Boston Scientific Company Information
  45. 6.8.2 Boston Scientific Business Overview
  46. 6.8.3 Boston Scientific PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Boston Scientific PVA Foam Embolization Particles Product Portfolio
  48. 6.8.5 Boston Scientific Recent Developments
  49. 6.9 Alicon
  50. 6.9.1 Alicon Company Information
  51. 6.9.2 Alicon Business Overview
  52. 6.9.3 Alicon PVA Foam Embolization Particles Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Alicon PVA Foam Embolization Particles Product Portfolio
  54. 6.9.5 Alicon Recent Developments
7 North America by Country
  1. 7.1 North America PVA Foam Embolization Particles Sales by Country
  2. 7.1.1 North America PVA Foam Embolization Particles Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America PVA Foam Embolization Particles Sales by Country (2021-2026)
  4. 7.1.3 North America PVA Foam Embolization Particles Sales Forecast by Country (2027-2032)
  5. 7.2 North America PVA Foam Embolization Particles Market Size by Country
  6. 7.2.1 North America PVA Foam Embolization Particles Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America PVA Foam Embolization Particles Market Size by Country (2021-2026)
  8. 7.2.3 North America PVA Foam Embolization Particles Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe PVA Foam Embolization Particles Sales by Country
  2. 8.1.1 Europe PVA Foam Embolization Particles Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe PVA Foam Embolization Particles Sales by Country (2021-2026)
  4. 8.1.3 Europe PVA Foam Embolization Particles Sales Forecast by Country (2027-2032)
  5. 8.2 Europe PVA Foam Embolization Particles Market Size by Country
  6. 8.2.1 Europe PVA Foam Embolization Particles Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe PVA Foam Embolization Particles Market Size by Country (2021-2026)
  8. 8.2.3 Europe PVA Foam Embolization Particles Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific PVA Foam Embolization Particles Sales by Country
  2. 9.1.1 Asia-Pacific PVA Foam Embolization Particles Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific PVA Foam Embolization Particles Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific PVA Foam Embolization Particles Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific PVA Foam Embolization Particles Market Size by Country
  6. 9.2.1 Asia-Pacific PVA Foam Embolization Particles Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific PVA Foam Embolization Particles Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific PVA Foam Embolization Particles Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America PVA Foam Embolization Particles Sales by Country
  2. 10.1.1 South America PVA Foam Embolization Particles Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America PVA Foam Embolization Particles Sales by Country (2021-2026)
  4. 10.1.3 South America PVA Foam Embolization Particles Sales Forecast by Country (2027-2032)
  5. 10.2 South America PVA Foam Embolization Particles Market Size by Country
  6. 10.2.1 South America PVA Foam Embolization Particles Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America PVA Foam Embolization Particles Market Size by Country (2021-2026)
  8. 10.2.3 South America PVA Foam Embolization Particles Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa PVA Foam Embolization Particles Sales by Country
  2. 11.1.1 Middle East and Africa PVA Foam Embolization Particles Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa PVA Foam Embolization Particles Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa PVA Foam Embolization Particles Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa PVA Foam Embolization Particles Market Size by Country
  6. 11.2.1 Middle East and Africa PVA Foam Embolization Particles Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa PVA Foam Embolization Particles Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa PVA Foam Embolization Particles Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 PVA Foam Embolization Particles Value Chain Analysis
  2. 12.1.1 PVA Foam Embolization Particles Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 PVA Foam Embolization Particles Production Mode & Process
  7. 12.2 PVA Foam Embolization Particles Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 PVA Foam Embolization Particles Distributors
  10. 12.2.3 PVA Foam Embolization Particles Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst